Search for: "Sanofi-Aventis" Results 101 - 120 of 563
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Nov 2009, 3:02 am
The top executive of French drug maker Sanofi-Aventis reached out to Boston-area researchers and biotechnology start-ups, offering "partnerships for innovation" that could range from investing in drugs to outright acquisitions, The Boston Globe reported. [read post]
8 Sep 2010, 2:37 am by By DEALBOOK
Sanofi-Aventis's chief executive Chris Viehbacher took his case for a takeover directly to Genzyme's investors in meetings in New York Tuesday, Bloomberg News reported, citing two people who attended. [read post]
29 Sep 2010, 2:24 am by By DEALBOOK
Genzyme's chief executive, Henri Termeer, has suggested he is more open Sanofi-Aventis's proposed takeover of the biotechnology company than at any point in the past, telling The Financial Times, he would be prepared step down to facilitate the deal. [read post]
27 Sep 2010, 4:19 am by By DEALBOOK
Sanofi-Aventis is looking to line up additional financing as it mulls upping its bid for Genzyme, The Wall Street Journal reported. [read post]
1 Jun 2009, 9:03 pm
Sanofi-Aventis bought BiPar to obtain rights to BiPar's BSI-201, which belongs to a new class of drugs that block a cell repair enzyme known as PARP. [read post]
21 Jun 2007, 5:49 am
Via Reuters:Switzerland has recommended that girls should be vaccinated with Gardasil, the cervical cancer shot marketed by Merck Co Inc (MRK.N: Quote, Profile, Research) and Sanofi-Aventis SA (SASY.PA: Quote, Profile, Research) in Europe, the firms said on Monday. [read post]
1 Apr 2007, 7:20 am
KETEK (telithromycin), manufactured and sold by Sanofi-aventis U.S. recently decided, after prompting by the U.S. [read post]
4 Feb 2023, 5:28 pm by Ron Coleman
Per the EFF, Sanofi-Aventis backed down: “Under terms of Tuesday’s settlement, AcompliaReport.com keeps its domain name, as long as there is a disclaimer stating... [read post]
11 Jun 2007, 10:03 pm
According to recent reports, Zimulti, an obesity drug manufactured by Sanofi-Aventis SA has been linked to an increase in suicidal thoughts in its consumers. [read post]
7 Jan 2008, 9:21 pm
Per the Chamber-backed Madison County Record, forty-seven plaintiffs from around the country have been brought to the southern Illinois county to sue drugmaker Sanofi-Aventis over alleged complications of the antibiotic Ketek. [read post]
9 Mar 2010, 1:24 pm by Zach Lowe
Merck and Sanofi-Aventis have agreed to merge their animal health units, essentially undoing a prior deal that separated those interests as a way of helping Merck clear regulatory hurdles on its way to a $41 billion merger with Schering-Plough. [read post]
8 Nov 2010, 11:58 am by By MICHAEL J. DE LA MERCED
Sanofi-Aventis on Monday sent a letter to Genzyme's chief executive, asking that the biotech giant not seek to block its unsolicited takeover bid by altering its board or using anti-takeover laws in its home state, Massachusetts. [read post]
9 Jun 2008, 4:50 am
Sanofi-Aventis Deutschland GMBH et al. 2:08-cv-00258; filed June 5, 2008 in the Eastern District of Virginia Declaratory judgment of non-infringement and invalidity of U.S. [read post]
6 Jan 2017, 6:04 pm by Michael Baseluos
The FDA  found Sanofi Aventis in violation of the Federal Food, Drug, and Cosmetic Act. [read post]
6 Jan 2017, 6:04 pm by Michael Baseluos
The FDA  found Sanofi Aventis in violation of the Federal Food, Drug, and Cosmetic Act. [read post]
28 Apr 2015, 2:36 am by Mark Summerfield
A court ruling has revealed that the Commonwealth of Australia (i.e. the Federal Government) is seeking to recover $60 million it considers has been ‘overpaid’ for the anti-clotting drug marketed by Sanofi (formerly Sanofi-Aventis) and Bristol-Meyers Squibb under the brand name PLAVIX: Commonwealth of Australia v Sanofi-Aventis [2015] FCA 384.Sanofi was the owner of Australian Patent No. 597784, which includes claims directed to the… [read post]
3 Aug 2010, 9:47 pm by Patent Docs
Noonan -- Last Friday, sanofi-aventis and Microsoft joined in filing an amicus curiae brief with the Federal Circuit in the Therasense, Inc. v. [read post]
16 Jul 2010, 2:44 pm
On July 13, 2010, the Food and Drug Administration reported in a drug safety alert, that it is requiring Sanofi-Aventis to place a black box warning on its rheumatoid arthritis drug, Arava. [read post]